Middle East FinTech today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East FinTech today.

Press releases published on August 7, 2026

9 hours ago

Birchtech Announces Results of Voting from Annual Meeting of Stockholders

Indeterminate GlobeNewswire

9 hours ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

9 hours ago

Atico Announces 2026 AGM Voting Results and Stepdown of Michael Winn as Director

Indeterminate GlobeNewswire

9 hours ago

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

9 hours ago

NI Holdings, Inc. Reports Results for Second Quarter Ended June 30, 2026

Indeterminate GlobeNewswire

Aug. 7, 2026

Understanding the September 30 EB-5 Deadline: What It Means for Investors

Indeterminate EIN Presswire

9 hours ago

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

9 hours ago

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

9 hours ago

Entera Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

9 hours ago

Globus Maritime Limited Reports Financial Results for the Second Quarter and Six-Month Period Ended June 30, 2026

Indeterminate GlobeNewswire

9 hours ago

Capital Clean Energy Carriers Corp. Announces Annual Meeting of Shareholders

Indeterminate GlobeNewswire

9 hours ago

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

9 hours ago

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

9 hours ago

Amwell makes grant to new employees under inducement plan

Indeterminate GlobeNewswire

9 hours ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

9 hours ago

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Indeterminate GlobeNewswire

9 hours ago

Senvest Capital Inc. annonce ses rėsultats pour le trimestre terminé le 30 juin 2026

Indeterminate GlobeNewswire

9 hours ago

Senvest Capital Inc. Reports Results for the Second Quarter Ended June 30, 2026

Indeterminate GlobeNewswire

9 hours ago

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

9 hours ago

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire